• Home
  • Beijing Sunho Pharmaceutical Co., Ltd

Beijing Sunho Pharmaceutical Co., Ltd

  • Beijing Sunho
  • Appearance
  • Guangdong Sunho
About Beijing Sunho Pharmaceutical Co., Ltd

Founded in 2000, we are an innovative pharmaceutical company specializing in advanced drug delivery systems. Our three core technology platforms - controlled-release formulations, orally disintegrating tablets, and complex injectables - enable us to provide end-to-end CDMO services from preclinical development to commercial manufacturing. With EMA certification (2022) and successful US FDA inspection (2023), we are committed to becoming a globally leading CMC & CMO service provider with globally compliant quality systems.

Read more Show less
Certifications
  • FDA
    FDA
  • GMP
    GMP
  • Other
More certifications Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    China
  • On CPHI since:
    2024
  • Certificates:
    3
  • Employees:
    500 - 999
Company types
CMO/CDMO
Pharmaceutical company
Primary activities
Contract Manufacturer
Pharmaceutical Company (generic finished products)
Contact info
  • +86-010-67888388
  • No. 18 Zhonghe St., Economy and Technology, Development Zone, Beijing, China
Show contact info Hide contact info
Meet us at

CPHI Milan 2026

Fiera Milano, Italy
6 Oct 2026 - 8 Oct 2026
View Exhibitor Profile

Products from Beijing Sunho Pharmaceutical Co., Ltd (6)

Beijing Sunho Pharmaceutical Co., Ltd Resources (2)

  • News Top 20 Chinese CDMO Enterprises in 2025

    Beijing Sunho Pharmaceutical was honored once again as one of the top 20 Chinese pharmaceutical CDMO enterprises in 2025.
    1 Jul 2025
  • Top 20 Chinese CDMO Enterprises in 2023

    News Top 20 Chinese CDMO Enterprises in 2023

    On June 16, 2023, the "2023 Conference on High Quality Development of Healthcare Industry and the 8th Summit for China Pharmaceutical R&D Innovation" was held in Chongqing. This summit has created more high-value communication and cooperation opportunities for pharmaceutical companies to understand the latest cutting-edge developments in pharmaceutical preparations, promote cooperation in drug quality and new formulation development, and create a suitable and competitive R&D pipeline to enhance the market competitiveness of companies.The conference released the list of "Top 20 Chinese CDMO Enterprises in 2023". And Sunho Pharmaceutical was honored to be in the list, which is another high recognition of the industry's professionalism in the field of CDMO services. In the future, Sunho will continue to adhere to the core concept of "Self-surpassing and Co-development" to provide more professional and better services for our customers.
    27 Aug 2024